|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to New York Times Health News Archives
New York Times Health News: 12-08-2004
In negotiating to buy Guidant, Johnson & Johnson is looking for an acquisition to increase its presence in the lucrative, fast-growing market for medical devices.
The directors of Merck, the giant drug maker, have opened an independent investigation into whether the company acted properly regarding Vioxx.
Despite a barrage of new ideas, the hangover itself is imperfectly understood and a true cure remains elusive.
Sometimes, it is only when the patient is halfway out the door that important information spills out.
Two drugs approved for the treatment of irritable bowel syndrome may or may not work for the 45 million Americans who suffer from the disorder.
For elderly people who need a little help, a new study suggests that taking a cruise may be a legitimate alternative to assisted living.
|
|
